Synergy Chc Corp Stock Price, News & Analysis

Synergy CHC Corp. (NASDAQ: SNYR) has appointed Damian Marano as Vice President of Beverage to drive its FOCUSfactor Energy Drink expansion globally. Marano brings over 20 years of industry experience, notably from Coca-Cola where he managed a $200M ARR portfolio and secured $2B in annual renewals. His track record includes founding Docklight Brands, scaling the Marley wellness portfolio to 25,000+ retail locations across 40+ countries. At Synergy, Marano will focus on expanding the FOCUSfactor Energy Drinks line, which features B-vitamins and nootropics for mental clarity. The company is leveraging its established FOCUSfactor brand presence in major retailers like Costco, Walmart, Amazon, and CVS to penetrate the functional beverage market.

Synergy CHC Corp. (NASDAQ: SNYR) has secured a $20 million term loan credit agreement with ACP Agency, LLC, extending through May 2029. The company received $15 million upfront at SOFR plus 8.5% interest rate, with interest-only payments through 2025. Starting January 2026, quarterly principal payments begin at $175,000, increasing to $350,000 per quarter from 2027. The facility includes a $2.5 million delayed draw facility and $2.5 million uncommitted term loan incremental facility. The refinancing aims to strengthen Synergy's capital structure, repay existing debt, and provide growth capital. The company will use the delayed draw proceeds to fully repay debt related to settlement agreements.

Synergy CHC Corp. (NASDAQ: SNYR) has appointed Erik Shields as Vice President of Beverage, effective May 26, 2025. Shields brings nearly 20 years of sales leadership experience in both alcoholic and non-alcoholic beverage categories. He previously served as Director of C-Store Sales at Trilliant Food & Nutrition and holds certification as a Cicerone®.

The appointment comes as Synergy expands its flagship brain health brand, FOCUSfactor, into the functional beverage category with the launch of Focus + Energy Drinks. These beverages are formulated with B-vitamins and nootropics for clean energy and focus. In his new role, Shields will lead go-to-market strategy, distribution, and brand execution for this new product line.

Synergy CHC Corp (NASDAQ: SNYR) reported its Q1 2025 financial results, marking its ninth consecutive quarter of profitability. The company achieved a 30% growth in earnings per share to $0.10 compared to $0.08 in Q1 2024. While revenue decreased 13% to $8.2 million from $9.4 million, gross margin improved to 75.4% from 72.0%. Net income increased 51% to $876.3 thousand, and EBITDA grew 7% to $1.98 million. Operating expenses decreased 15% to $4.2 million. The company is pursuing international expansion for its FOCUSfactor brand and Ready-To-Drink beverages into three new markets. Synergy has entered debt refinancing negotiations to extend maturity to 2029, established a subsidiary in Mexico, and signed a new long-term supplier agreement for FOCUSfactor products. The company reduced outstanding liabilities by $1.7 million during Q1 2025.

Synergy CHC Corp. (NASDAQ: SNYR), a consumer health care and lifestyle products provider, has scheduled its Q1 2025 earnings release for Thursday, May 15, 2025, before market opening. The company will host a conference call at 9:00 a.m. ET / 6:00 a.m. PT on the same day.

CEO Jack Ross and CFO Jaime Fickett will lead the conference call. Participants can access the live webcast through Synergy's Investor Relations website and are encouraged to dial in 15 minutes before the start time. A replay will be available on the company's website for a limited time.

Synergy CHC Corp (NASDAQ: SNYR) reported its Q4 and full-year 2024 financial results, marking its eighth consecutive quarter of profitability. Q4 2024 showed revenue of $10.3M (down 22% YoY), with net income of $105.7K and EPS of $0.01. Full-year 2024 results included revenue of $34.8M (down 19% YoY), net income of $2.1M, and EPS of $0.28.

The company completed its IPO in October 2024, offering 1,150,000 shares at $9.00 per share. Notable developments include expanded partnerships with BJ's Wholesale Clubs and Publix, reduced debt by $4.5M in Q4, and the appointment of Jaime Fickett as permanent CFO. The revenue decline was primarily attributed to FOCUSfactor rebranding and retailer de-inventorying, which the company states is now behind them as they enter 2025.

Synergy CHC Corp. (NASDAQ: SNYR), a consumer health care and lifestyle products provider, has scheduled the release of its Q4 and full year 2024 financial results for Monday, March 31, 2025, before market opening.

The company will host a conference call at 9:00 a.m. ET / 6:00 a.m. PT on the same day, featuring CEO Jack Ross and CFO Jaime Fickett. Participants are encouraged to join 15 minutes before the start time. The call will be accessible through a live webcast on Synergy's Investor Relations website, with a replay available for a time.

Synergy CHC Corp (NASDAQ: SNYR), a consumer health care and lifestyle products provider, has announced its participation in the upcoming 37th Annual ROTH Conference. The event will take place from March 16-18, 2025, in Dana Point, California.

The company's management team will be available during the conference for one-on-one meetings with investors. Interested parties are advised to contact their ROTH sales representative to schedule meetings.

Synergy CHC Corp. (NASDAQ: SNYR) reported its Q3 2024 financial results, marking its seventh consecutive profitable quarter. Revenue decreased 34% to $7.1 million compared to $10.8 million in Q3 2023, primarily due to retailer de-inventorying related to FOCUSfactor product rebranding.

Key financial metrics include: gross margin of 67.2% (down from 72.0%), operating income of $1.1 million (down from $2.1 million), and net income of $0.8 million (down from $1.3 million). The company completed its IPO of 1,150,000 shares at $9.00 per share and expanded retail partnerships with BJ's Wholesale Clubs and Publix. Post-IPO, Synergy reduced debt by $3.1 million and added $6.2 million in net cash to its balance sheet.